http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-3072001-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
filingDate 1999-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba554f0ac89ae2e027be01e2be7fc5fa
publicationDate 2002-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SK-3072001-A3
titleOfInvention Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
abstract The present invention relates to an oral compacted composition comprising entacapone, nitecapone, or a pharmaceutically acceptable salt thereof and a cross-linked cellulose derivative. The composition is premised on the discovery that the cross-linked cellulose derivative increases the release rate of entacapone or nitecapone from an oral compacted composition. Preferably the amount of the cross-linked cellulose derivative in the composition is at least 6 % by weight, preferably from about 8 % to about 16 % weight, especially from about 10 % to about 14 % by weight.
priorityDate 1998-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503278
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8WZ04
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432099778
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A193KX02
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425304861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453335048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB6CZ62
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86243
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB6CZ46
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO07431
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22734
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB6CZ56
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154167567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517347
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA4IG53
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464105
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ99028
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA7MBI7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8NKC1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA1Y9I9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO88587
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21964
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO42898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281081

Total number of triples: 49.